State Of Wyoming Intellia Therapeutics, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$38.49 - $76.21 $230 - $457	-6 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $233 - $475	-4 Reduced 40.0%	6 $0
Q4 2021 Feb 11, 2022	SELL	$100.76 - $138.36 $2,418 - $3,320	-24 Reduced 70.59%	10 $1,000
Q3 2021 Feb 11, 2022	BUY	$132.37 - $176.78 $4,500 - $6,010	34 New	34 $5,000
Q2 2021 Feb 11, 2022	SELL	$60.88 - $161.91 $304 - $809	-5 Closed	0 $0
Q1 2021 Feb 08, 2022	BUY	$46.59 - $83.68 $232 - $418	5 New	5 $0

326

88.8M

673K

865K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.6B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.